Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.2000 (-0.92%) ($30.9000 - $32.2000) on Thu. May. 26, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 32 | Latest Price | $32.2000(-0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWG(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.625% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
1 - 5 Day Possible Target | $19.97(-37.98%) | Resistance Level | $34.65 | 5 Day Moving Average | $32.47(-0.83%) | 10 Day Moving Average | $32.96(-2.31%) | 20 Day Moving Average | $34.65(-7.07%) | To recent high | -22.8% | To recent low | 53.3% | Market Cap | $634m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |